Multiple Sclerosis is a chronic inflammatory condition that impacts the central nervous system, which encompasses both the brain and the spinal cord. 

It is largely categorized as an autoimmune disorder, meaning the body's own immune system mistakenly targets and attacks its healthy tissues. 

Given that the precise cause of MS is not yet fully understood, preventing its onset is not currently possible, and there is no known cure. 

MS stands as the most common autoimmune disorder affecting the central nervous system, with an estimated 2 million people worldwide living with the condition as of 2008. 

Since a definitive cure for MS is not yet available, treatment strategies primarily focus on helping patients recover from acute attacks, slowing down the disease's progression over time, and meticulously managing its diverse symptoms. 

In a double-blind, sham-controlled study using BrainsWay Deep TMS ™, MS patients demonstrated significant improvements in measures of fatigue and depressive symptoms. These positive changes were observed after a six-week Deep TMS treatment regimen applied over the motor cortex.

Another double-blind, sham-controlled Deep TMS study revealed that active Deep TMS treatment led to significant improvements in both the speed and endurance of walking ability in MS patients. 

These findings suggest that Deep TMS may offer tangible benefits for functional mobility in individuals with MS. 

In Summary

Multiple Sclerosis is a complex and chronic autoimmune condition of the central nervous system with no known cure.

While conventional treatments aim to manage attacks and slow progression, Deep TMS is emerging as a promising, non-invasive therapeutic option. 

Clinical studies highlight its potential to significantly improve symptoms such as fatigue, depression, and even walking ability in MS patients